Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups
High tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer patient populations, researchers report on September 29 in the journal Cancer ...
Sep 29, 2022
0
64
